Semler Scientific (SMLR) Competitors

Semler Scientific logo
$47.69 +0.71 (+1.51%)
Closing price 02/12/2025 04:00 PM Eastern
Extended Trading
$47.22 -0.47 (-0.99%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SMLR vs. CDRE, PLSE, LQDA, RXST, INMD, AORT, MDXG, BLFS, FNA, and EMBC

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Cadre (CDRE), Pulse Biosciences (PLSE), Liquidia (LQDA), RxSight (RXST), InMode (INMD), Artivion (AORT), MiMedx Group (MDXG), BioLife Solutions (BLFS), Paragon 28 (FNA), and Embecta (EMBC). These companies are all part of the "medical equipment" industry.

Semler Scientific vs.

Semler Scientific (NASDAQ:SMLR) and Cadre (NYSE:CDRE) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.

Semler Scientific has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500.

In the previous week, Cadre had 2 more articles in the media than Semler Scientific. MarketBeat recorded 4 mentions for Cadre and 2 mentions for Semler Scientific. Cadre's average media sentiment score of 0.81 beat Semler Scientific's score of 0.28 indicating that Cadre is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Semler Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cadre
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cadre received 14 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 66.67% of users gave Semler Scientific an outperform vote while only 55.17% of users gave Cadre an outperform vote.

CompanyUnderperformOutperform
Semler ScientificOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
CadreOutperform Votes
16
55.17%
Underperform Votes
13
44.83%

49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by company insiders. Comparatively, 37.0% of Cadre shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Semler Scientific currently has a consensus target price of $71.00, suggesting a potential upside of 48.88%. Cadre has a consensus target price of $39.75, suggesting a potential upside of 11.63%. Given Semler Scientific's stronger consensus rating and higher probable upside, research analysts plainly believe Semler Scientific is more favorable than Cadre.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cadre
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Semler Scientific has a net margin of 27.00% compared to Cadre's net margin of 6.34%. Semler Scientific's return on equity of 20.31% beat Cadre's return on equity.

Company Net Margins Return on Equity Return on Assets
Semler Scientific27.00% 20.31% 18.78%
Cadre 6.34%12.88%6.06%

Cadre has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semler Scientific$68.18M6.48$20.58M$2.0523.26
Cadre$516.16M2.80$38.64M$0.8342.90

Summary

Semler Scientific and Cadre tied by winning 9 of the 18 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$462.63M$3.46B$5.74B$9.10B
Dividend YieldN/A1.59%5.31%4.00%
P/E Ratio23.2612.3864.4615.62
Price / Sales6.4863.641,007.8479.25
Price / Cash16.2044.0546.0938.87
Price / Book4.563.815.135.00
Net Income$20.58M$90.91M$113.24M$222.75M
7 Day Performance-4.47%1.99%-1.42%-1.01%
1 Month Performance-9.51%8.34%4.82%4.04%
1 Year Performance2.76%16.66%25.22%21.71%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
2.9301 of 5 stars
$47.69
+1.5%
$71.00
+48.9%
-0.9%$462.63M$68.18M23.26120Short Interest ↑
Gap Down
CDRE
Cadre
3.6434 of 5 stars
$36.20
+2.2%
$39.75
+9.8%
+0.4%$1.47B$482.53M43.612,435Short Interest ↑
PLSE
Pulse Biosciences
1.1507 of 5 stars
$22.36
+2.7%
N/A+155.5%$1.38B$700,000.000.00140Gap Down
LQDA
Liquidia
2.7875 of 5 stars
$16.22
+3.0%
$25.38
+56.4%
+7.9%$1.37B$17.49M-9.9550
RXST
RxSight
2.9422 of 5 stars
$32.06
-3.0%
$58.13
+81.3%
-37.2%$1.29B$89.08M-38.63220
INMD
InMode
1.858 of 5 stars
$18.54
+2.8%
$23.00
+24.1%
-28.7%$1.29B$394.82M7.89480Short Interest ↑
AORT
Artivion
1.4527 of 5 stars
$30.50
-0.2%
$31.80
+4.3%
+69.7%$1.28B$354M-1,524.751,500Upcoming Earnings
Gap Down
MDXG
MiMedx Group
3.5471 of 5 stars
$8.35
+0.5%
$12.00
+43.7%
-1.2%$1.23B$321.48M15.18870
BLFS
BioLife Solutions
2.0156 of 5 stars
$25.91
-0.7%
$29.43
+13.6%
+40.0%$1.20B$143.27M-24.44440News Coverage
Gap Down
FNA
Paragon 28
2.4781 of 5 stars
$13.09
+0.5%
$14.60
+11.6%
-10.2%$1.10B$216.39M-17.68343,000Short Interest ↓
EMBC
Embecta
4.54 of 5 stars
$17.50
+0.5%
$23.00
+31.4%
+11.0%$1.02B$1.12B17.502,100Earnings Report
Dividend Announcement
Short Interest ↓
Gap Down

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 2/13/2025 by MarketBeat.com Staff
From Our Partners